Kyle Carver insider trades

Open-market stock purchases and sales by Kyle Carver, Chief Financial Officer at Evommune, Inc, from SEC Form 4 filings since Dec 14, 2018.

Track record: 0% of 1 scored buy are up 5% or more since purchase, averaging -61%.

Recent trades

DateStockTradeValue
Jul 8, 2026EVMN Evommune, IncBought$13.3K
May 28, 2026EVMN Evommune, IncSold$415K
May 28, 2026EVMN Evommune, IncBought (not open market)—
Apr 16, 2026EVMN Evommune, IncBought (not open market)—
Dec 9, 2025EVMN Evommune, IncSold (not open market)$237K
Nov 7, 2025EVMN Evommune, IncBought (not open market)—
Nov 7, 2025EVMN Evommune, IncBought (not open market)—
Nov 5, 2025EVMN Evommune, IncBought (not open market)—

Companies traded

  • EVMN Evommune, Inc: 1 buy, 1 sale, last Jul 8, 2026
  • KDMN Kadmon Holdings, Inc: other filings, last Nov 9, 2021

Get free alerts when Kyle Carver files a new trade →